These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 236714)
1. The present and potential role of dimethyl sulfoxide in connective tissue disorders. Baum J Ann N Y Acad Sci; 1975 Jan; 243():391-2. PubMed ID: 236714 [No Abstract] [Full Text] [Related]
2. [About some effects of dimethyl sulfoxide (DMSO) in percutaneous use]. Kappert A Schweiz Med Wochenschr; 1968 Nov; 98(46):1829-37. PubMed ID: 5705674 [No Abstract] [Full Text] [Related]
3. Design of therapeutic trials for dimethyl sulfoxide. Kantor TG Ann N Y Acad Sci; 1975 Jan; 243():390. PubMed ID: 1055554 [No Abstract] [Full Text] [Related]
4. A clinical study on the effects of dimethyl sulfoxide in 103 patients with acute and chronic musculoskeletal injuries and inflammations. Lockie LM; Norcross BM Ann N Y Acad Sci; 1967 Mar; 141(1):599-602. PubMed ID: 5232268 [No Abstract] [Full Text] [Related]
5. Dimethyl sulfoxide in musculoskeletal disorders. Demos CH; Beckloff GL; Donin MN; Oliver PM Ann N Y Acad Sci; 1967 Mar; 141(1):517-23. PubMed ID: 5232264 [No Abstract] [Full Text] [Related]
6. [Dermatological experience with dimethyl sulfoxide (DMSO)]. Weitgasser H Z Haut Geschlechtskr; 1967 Sep; 42(18):749-54. PubMed ID: 5591425 [No Abstract] [Full Text] [Related]
7. Dimethyl sulfoxide (DMSO): laboratory and clinical evaluation. Jacob SW; Herschler RJ; Rosenbaum EE J Am Vet Med Assoc; 1965 Dec; 147(12):1350-9. PubMed ID: 5894316 [No Abstract] [Full Text] [Related]
8. The use of corticosteroid agents in connective tissue disorders. Barraclough D Med J Aust; 1986 Apr; 144(8):427-32. PubMed ID: 2870416 [No Abstract] [Full Text] [Related]
9. Discussion paper: methodology and techniques in the evaluation of dimethyl sulfoxide for connective tissue disorders. Fleischmajer R Ann N Y Acad Sci; 1975 Jan; 243():393-4. PubMed ID: 1055555 [No Abstract] [Full Text] [Related]
10. Successful treatment with low-dose weekly methotrexate in a case of undifferentiated spondyloarthropathy coexisting with cutaneous polyarteritis nodosa. Queiro R; De Dios JR Clin Rheumatol; 2002 Aug; 21(4):304-5. PubMed ID: 12189458 [TBL] [Abstract][Full Text] [Related]
11. Clinical experience with DMSO in acute musculoskeletal conditions comparing a noncontrolled series with a controlled double blind study. Brown JH Ann N Y Acad Sci; 1967 Mar; 141(1):496-505. PubMed ID: 5342263 [No Abstract] [Full Text] [Related]
13. Clinical experiences with the topical application of DMSO in orthopedic diseases: evaluation of 4180 cases. John H; Laudahn G Ann N Y Acad Sci; 1967 Mar; 141(1):506-16. PubMed ID: 5232263 [No Abstract] [Full Text] [Related]
14. Indications and contraindications for the use of DMSO in clinical dermatology. Engel MF Ann N Y Acad Sci; 1967 Mar; 141(1):638-45. PubMed ID: 5233139 [No Abstract] [Full Text] [Related]
15. [Studies on subcutaneous fibroses following cobalt teletherapy and their treatment possibilities with dimethyl sulfoxide (DMSO)]. Frommhold W; Bublitz G Strahlentherapie; 1967 Aug; 133(4):529-38. PubMed ID: 5591714 [No Abstract] [Full Text] [Related]
16. Dimethyl sulfoxide: a review of its use in the rheumatic disorders. Trice JM; Pinals RS Semin Arthritis Rheum; 1985 Aug; 15(1):45-60. PubMed ID: 3898376 [No Abstract] [Full Text] [Related]
17. [Centrally caused or general analgetic effect of locally administered dimethyl sulfoxide (DMSO)]. von der Hardt H; Röper HJ; Sudhof H Med Welt; 1969 Mar; 11():606-9. PubMed ID: 5305762 [No Abstract] [Full Text] [Related]
18. Failure of dimethyl sulfoxide in the treatment of scleroderma. Binnick SA; Shore SS; Corman A; Fleischmajer R Arch Dermatol; 1977 Oct; 113(10):1398-402. PubMed ID: 911168 [TBL] [Abstract][Full Text] [Related]
19. Experimental and clinical evaluation of topical dimethyl sulfoxide in venous disorders of the extremities. Kappert A Ann N Y Acad Sci; 1975 Jan; 243():403-7. PubMed ID: 1055557 [No Abstract] [Full Text] [Related]
20. [Preliminary results with antimetabolite therapy of autoaggressive diseases in dermatology]. Schirren CG Munch Med Wochenschr; 1965 Dec; 107(50):2553-7. PubMed ID: 4380581 [No Abstract] [Full Text] [Related] [Next] [New Search]